[
  {
    "ts": null,
    "headline": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
    "summary": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
    "url": "https://finnhub.io/api/news?id=7a543421532715472fe76ab340824534055f07bbab4dc5aca600ad311e8b8262",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744825893,
      "headline": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
      "id": 133937743,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7a543421532715472fe76ab340824534055f07bbab4dc5aca600ad311e8b8262"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "AbbVie Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a76ef1c310b272dcfbc303135f935cc11dd8a8baadd841114896c0565f41f9ab",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744821120,
      "headline": "AbbVie Inc. stock underperforms Wednesday when compared to competitors",
      "id": 133945931,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a76ef1c310b272dcfbc303135f935cc11dd8a8baadd841114896c0565f41f9ab"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now",
    "summary": "We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]",
    "url": "https://finnhub.io/api/news?id=ca052142215b1c4e69d9cc6c52d6bc2d4886543fa30f4eb5520e873875f14adb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744816851,
      "headline": "AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now",
      "id": 133935638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]",
      "url": "https://finnhub.io/api/news?id=ca052142215b1c4e69d9cc6c52d6bc2d4886543fa30f4eb5520e873875f14adb"
    }
  },
  {
    "ts": null,
    "headline": "IYH: Healthcare Dashboard For April",
    "summary": "IYH: Healthcare Dashboard For April",
    "url": "https://finnhub.io/api/news?id=ef60e7fe50c851812342eddac8f56058cf17e7e5c0696e76992c679d592b9289",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744814463,
      "headline": "IYH: Healthcare Dashboard For April",
      "id": 133936894,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ef60e7fe50c851812342eddac8f56058cf17e7e5c0696e76992c679d592b9289"
    }
  },
  {
    "ts": null,
    "headline": "Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).",
    "url": "https://finnhub.io/api/news?id=026dabbb2a99de471029a5b9ad880404d285a1fb63b67599c647a2c657d23bbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744794365,
      "headline": "Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks",
      "id": 133935639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).",
      "url": "https://finnhub.io/api/news?id=026dabbb2a99de471029a5b9ad880404d285a1fb63b67599c647a2c657d23bbe"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment",
    "summary": "AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=63066853a15be3643b03be22e4133cb973022cddbaf7c34d0a02dd22dc1a2e35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744792380,
      "headline": "The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment",
      "id": 133932750,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=63066853a15be3643b03be22e4133cb973022cddbaf7c34d0a02dd22dc1a2e35"
    }
  }
]